We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

253 hedge funds and large institutions have $5.19B invested in PHARMACYCLICS INC in 2013 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 86 increasing their positions, 80 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 41

50% more funds holding in top 10

Funds holding in top 10: 812 (+4)

17% more call options, than puts

Call options by funds: $209M | Put options by funds: $178M

13% more funds holding

Funds holding: 224253 (+29)

8% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 80

21% less capital invested

Capital invested by funds: $6.59B → $5.19B (-$1.41B)

Holders
253
Holders Change
+29
Holders Change %
+12.95%
% of All Funds
7.34%
Holding in Top 10
12
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+50%
% of All Funds
0.35%
New
71
Increased
86
Reduced
80
Closed
41
Calls
$209M
Puts
$178M
Net Calls
+$30.5M
Net Calls Change
+$104M
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$922M -$35.3M -290,993 -3%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$809M -$72.1M -594,335 -7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$343M +$4.4M +36,259 +1%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$302M -$1.21M -9,934 -0.3%
Primecap Management
5
Primecap Management
California
$252M -$60.7K -500 -0%
Capital World Investors
6
Capital World Investors
California
$207M -$141M -1,163,578 -37%
BIT
7
BlackRock Institutional Trust
California
$184M +$44.1M +363,550 +26%
CCI
8
Columbus Circle Investors
$144M +$41.7M +343,332 +34%
State Street
9
State Street
Massachusetts
$123M +$36.1M +297,687 +34%
FAM
10
Fred Alger Management
New York
$113M +$59M +486,034 +83%
Goldman Sachs
11
Goldman Sachs
New York
$102M +$47.7M +393,423 +69%
SCA
12
SAC Capital Advisors
Connecticut
$99.4M +$65.3M +537,917 +134%
JHIU
13
Janus Henderson Investors US
Colorado
$68.1M +$13.1M +107,792 +20%
Ameriprise
14
Ameriprise
Minnesota
$67.6M +$3.96M +32,608 +5%
BB
15
BB Biotech
Switzerland
$67.3M +$28.8M +237,512 +60%
Norges Bank
16
Norges Bank
Norway
$62.6M -$1.61M -13,263 -2%
First Trust Advisors
17
First Trust Advisors
Illinois
$48.9M +$49M +404,045 +699%
Northern Trust
18
Northern Trust
Illinois
$48.3M +$17.6M +144,896 +46%
BFA
19
BlackRock Fund Advisors
California
$47.2M +$2.55M +20,976 +5%
ZE
20
ZBI Equities
New York
$40.8M +$46.8M +385,814 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$36.5M +$16.6M +136,375 +65%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$34.2M +$1.83M +15,116 +5%
HH
23
HWG Holdings
Texas
$33.6M +$38.5M +317,572 New
TCIM
24
TIAA CREF Investment Management
New York
$32.4M +$2.05M +16,919 +6%
UBS AM
25
UBS AM
Illinois
$32.3M +$9.24M +76,109 +33%

PCYC Hedge Fund Activity: Q4 2013 in Review

253 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q4 2013, worth a combined $5.19B — down 21% from $6.59B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new PCYC positions and 41 closed out — a net gain of 30 holders — while 86 added to existing stakes and 80 trimmed.

The largest buyer was SAC Capital Advisors, adding an estimated $65.3M. The largest seller was Capital World Investors, cutting an estimated $141M.

  • 253 institutional investors held PHARMACYCLICS INC (PCYC) as of Q4 2013, up from 224 in Q3 2013.
  • Funds reported $5.19B of PHARMACYCLICS INC stock for Q4 2013, down 21% quarter-over-quarter.
  • 71 funds opened new PHARMACYCLICS INC positions in Q4 2013 and 41 closed out, a net change of +30 holders.
  • The largest PHARMACYCLICS INC buyer in Q4 2013 was SAC Capital Advisors, an estimated $65.3M added.
  • The largest PHARMACYCLICS INC seller in Q4 2013 was Capital World Investors, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.